Cargando…

Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2 Protein-Protein Interaction–a Mechanism that can Contribute to its Antiviral Activity Against COVID-19

Due to our interest in the chemical space of organic dyes to identify potential small-molecule inhibitors (SMIs) for protein-protein interactions (PPIs), we initiated a screen of such compounds to assess their inhibitory activity against the interaction between SARS-CoV-2 spike protein and its cogna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bojadzic, Damir, Alcazar, Oscar, Buchwald, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838506/ https://www.ncbi.nlm.nih.gov/pubmed/33519460 http://dx.doi.org/10.3389/fphar.2020.600372

Ejemplares similares

Design, Synthesis, and Evaluation of Novel Immunomodulatory Small Molecules Targeting the CD40–CD154 Costimulatory Protein-Protein Interaction
por: Bojadzic, Damir, et al.
Publicado: (2018)

Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19
por: Chuang, Sung-Ting, et al.
Publicado: (2022)

Methylene Blue: Revisited
por: Ginimuge, Prashant R., et al.
Publicado: (2010)

A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
por: Tsegay, Kaleb B., et al.
Publicado: (2021)

Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike—ACE2 Protein–Protein Interaction from a Chemical Space of Privileged Protein Binders
por: Chuang, Sung-Ting, et al.
Publicado: (2022)

Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies
por: Taldaev, Amir, et al.
Publicado: (2023)

3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor
por: Liang, Taizhen, et al.
Publicado: (2021)

Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches
por: Zareei, Sara, et al.
Publicado: (2022)

TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds
por: Haga, Shiori, et al.
Publicado: (2010)

Cervids ACE2 Residues that Bind the Spike Protein can Provide Susceptibility to SARS-CoV-2
por: Lopes, Luciano Rodrigo
Publicado: (2023)

Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells
por: Raghavan, Somasundaram, et al.
Publicado: (2022)

In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2021)

Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue
por: Ng, Jerome P. L., et al.
Publicado: (2022)

Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2
por: Pokhrel, Sushil, et al.
Publicado: (2021)

Revealing the Mechanism of SARS-CoV-2 Spike Protein Binding With ACE2
Publicado: (2020)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
por: Tyrankiewicz, Urszula, et al.
Publicado: (2021)

Antiviral photodynamic therapy: Inactivation and inhibition of SARS-CoV-2 in vitro using methylene blue and Radachlorin
por: Svyatchenko, Victor A., et al.
Publicado: (2021)

Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling
por: Balkrishna, Acharya, et al.
Publicado: (2022)

Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2
por: Chen, Xi, et al.
Publicado: (2022)

Modeling SARS-CoV-2 spike/ACE2 protein–protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context
por: Tragni, Vincenzo, et al.
Publicado: (2022)

A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2)
por: Zeng, Mao-Sen, et al.
Publicado: (2021)

Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction
por: Cao, Wenpeng, et al.
Publicado: (2021)

The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins
por: Conceicao, Carina, et al.
Publicado: (2020)

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
por: Luan, Junwen, et al.
Publicado: (2020)

Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies
por: Suresh, Voddu, et al.
Publicado: (2021)

The inhibitory effect of a coronavirus spike protein fragment with ACE2
por: Peter, Emanuel K., et al.
Publicado: (2021)

Perturbation of ACE2 Structural Ensembles by SARS-CoV-2 Spike Protein Binding
por: Uyar, Arzu, et al.
Publicado: (2021)

Modelling SARS-CoV-2 spike-protein mutation effects on ACE2 binding
por: Thakur, Shivani, et al.
Publicado: (2023)

Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs
por: Kazemi, Soheila, et al.
Publicado: (2021)

Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs
por: Kazemi, Soheila, et al.
Publicado: (2022)

Contact residue contributions to interaction energies between SARS-CoV-1 spike proteins and human ACE2 receptors
por: Rodriguez, Jorge H., et al.
Publicado: (2021)

Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
por: Francesconi, Oscar, et al.
Publicado: (2022)

Cholesteryl ester transfer protein: ace of spades, queen of hearts, or the joker?
por: Miller, Norman E.
Publicado: (2015)

Methylene-Blue in Fevers
por: Frost, G. H.
Publicado: (1908)

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021)

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
por: Chan, Kui K., et al.
Publicado: (2020)

The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
por: Procko, Erik
Publicado: (2020)

A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2
por: Bhattacharya, Rajarshi, et al.
Publicado: (2021)

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
por: Valencia, Inés, et al.
Publicado: (2020)

Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein
por: Heinzelman, Pete, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6reskk8groe4e9s0ssceejoskb